Transforming growth factor-β1 induces apoptosis in gastric cancer cells through a p53-independent pathway

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1628-1633

  Yamamoto, Manabu ^a   Maehara, Yoshihiko ^b   Sakaguchi, Yoshihisa ^b   Kusumoto, Tetsuya ^a   Ichiyoshi, Yuji ^b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

apoptosis; p53; TGF ; TGF receptor

Indexed keywords

DNA FRAGMENT; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CONFERENCE PAPER; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 0029925820     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960415)77:8<1628::aid-cncr31>3.0.co;2-%23     Document Type: Conference Paper

References (48)

1. Kizaki H, Ohnishi Y, Mizuno Y, Azuma Y, Mizuno Y, Ohsaka F. Arabinolcytosine and 5′ azacytisine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacology 1992;24:219-27.
2. Ling Y-H, Priebe W, Peterz-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and muitidrug resistance cells. Cancer Res 1993;53:1845-52.
3. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362:849-52.
4. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991;6:1915-22.
5. Columbel M, Olsson CA, Ng PY, Buttyan R. Hormone regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 1992; 52:4313-9.
6. Peitch MC, Plazar B, Stephan H, Crompton T, McDonald HR, Mannaherz HG, et al. Characterization of the endogenous deoxyribonuclease involved in apoptosis. EMBO J 1993; 12:371-83.
7. Cohen JJ. Overview: mechanism of apoptosis. Immunol Today 1993;14:126-30.
8. Cohen JJ, Duke RC. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10:267-93.
9. Arends MJ, Wyllie AH. Apoptosis: mechanism and role in pathology. Int Rev Exp Pathol 1991;32:223-54.
10. Kuerbitz SJ, Plunkett BS, Walsh WV, Kasta MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-5.
11. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, et al. A mammalian cell cycle check point pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992;71:587-97.
12. Lowe SW, Ruley ER, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
13. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 1981;78:5339-43.
14. 1 on proliferation and death of rat prostatic cells. Endocrinology 1990;127:2963-8.
15. Chen R-H, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993;260:1335-8.
16. Miyazono K, Ichijo H, Heldin C-H. Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors 1993;8:11-22.
17. 1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 1991;88:3412-5.
18. 1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 1992;52:4042-5.
19. 1. Proc Natl Acad Sci USA 1992;89:5408-12.
20. Fukuda K, Kojiro M, Chiu J-F. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology 1993;18:945-53.
21. 1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res 1993;53:3386-93.
22. Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M. Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res 1988;47:4134-40.
23. Chomczynski P, Sacchi N. Single step method of RNA isolated by acid guanidnium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Phillips RM, Sarang M, Gibson NW. Semi-quantitative measurement of gene expression by RT-PCR: a cautionary tale. Int J Oncol 1993;3:1097-102.
25. Franzen P, Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, et al. Cloning of a TGF β type I receptor that forms a heterometric complex with the TGF β type II receptor. Cell 1993;75:681-92.
26. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:7160-4.
27. Kolodner RD, Hall NR, Lipford J, Kane MF, Morrison PT, Finan PJ, et al. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res 1995;55:242-8.
28. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1885;316:701-5.
29. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
30. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45.
31. Lee G, Ellingsworth LR, Gillis S, Wall R, Kicard PW. β transforming growth factors are potential regulators of B lymphopoiesis. J Exp Med 1987;166:1290-99.
32. Morton DM, Barrack ER. Modulation of transforming growth factor β1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res 1995;55:2596-602.
33. Mukai M, Shinkai K, Komatsu K, Akeda H. Potentiation of invasion capacity of rat acites hepatoma cells by transforming growth factor-β. Jpn J Cancer Res 1986;80:107-10.
34. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 1985;82:119-23.
35. Havrilesky LJ, Hurteau JA, Whitaker RS, Elbendary A, Wu S, Rodriguez GC, et al. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor β. Cancer Res 1995;55:944-8.
36. Welch DR, Fabra A, Nakajima M. Transforming growth factor β stimulates mammary cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990;87:7678-82.
37. Alexandrow MG, Moses HL. Transforming growth factor β and cell cycle regulation. Cancer Res 1995;55:1452-7.
38. Jansen-Durr P, Meichel A, Steiner P, Pagano M, Finke K, Botz J, et al. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA 1993;90:3685-9.
39. Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, et al. Repression of cyclin D1: a novel function of MYC. Mol Cell Biol 1994;14:4032-43.
40. Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 1992;70:57-67.
41. Ito M, Yashui W, Kyo E, Yokozaki H, Nakayama H, Ito H, et al. Growth inhibition of transforming growth factor β on human gastric carcinoma cells: receptor and postreceptor signal. Cancer Res 1992;15:295-300.
42. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 1993;74:1009-20.
43. Wana JL, Attisano L, Caroamo J, Zentella A, Jacqueline D, Laiho M, et al. TGFβ signals through a heterometric protein kinase receptor complex. Cell 1992;71:1003-14.
44. KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
45. 1-treated M1 cells ectopically expressing B-myb. Cancer Res 1995;55:501-4.
46. Dulić V, Kaufmann W, Wilson SJ, Tlsty TD, Lees E. Harper JW, et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994;76:1013-23.
47. Khanna KK, Beamish H, Yan J, Hobson K, Williams R, Dunn I, et al. Nature of G1/S cell cycle check point defect in ataxiatelangiectasia. Oncogene 1995;11:609-18.
48. Greenblatt MS, Bennet WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-78.